GRI
Price
$0.75
Change
-$0.02 (-2.60%)
Updated
Dec 20, 04:59 PM (EDT)
NLSP
Price
$1.93
Change
-$0.45 (-18.91%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

GRI vs NLSP

Header iconGRI vs NLSP Comparison
Open Charts GRI vs NLSPBanner chart's image
GRI Bio
Price$0.75
Change-$0.02 (-2.60%)
Volume$6.52K
CapitalizationN/A
Nls Pharmaceutics
Price$1.93
Change-$0.45 (-18.91%)
Volume$100
CapitalizationN/A
GRI vs NLSP Comparison Chart
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRI vs. NLSP commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a Hold and NLSP is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (GRI: $0.74 vs. NLSP: $1.95)
Brand notoriety: GRI and NLSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 4% vs. NLSP: 53%
Market capitalization -- GRI: $6.61M vs. NLSP: $4.55M
GRI [@Biotechnology] is valued at $6.61M. NLSP’s [@Biotechnology] market capitalization is $4.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 1 FA rating(s) are green whileNLSP’s FA Score has 0 green FA rating(s).

  • GRI’s FA Score: 1 green, 4 red.
  • NLSP’s FA Score: 0 green, 5 red.
According to our system of comparison, GRI is a better buy in the long-term than NLSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 2 TA indicator(s) are bullish while NLSP’s TA Score has 5 bullish TA indicator(s).

  • GRI’s TA Score: 2 bullish, 6 bearish.
  • NLSP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NLSP is a better buy in the short-term than GRI.

Price Growth

GRI (@Biotechnology) experienced а -7.50% price change this week, while NLSP (@Biotechnology) price change was +2.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

GRI is expected to report earnings on May 10, 2023.

NLSP is expected to report earnings on May 05, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRI($6.61M) has a higher market cap than NLSP($4.55M). NLSP YTD gains are higher at: -91.736 vs. GRI (-97.888). GRI has higher annual earnings (EBITDA): -7.87M vs. NLSP (-12.02M). GRI has less debt than NLSP: GRI (131K) vs NLSP (1.63M). GRI (0) and NLSP (0) have equivalent revenues.
GRINLSPGRI / NLSP
Capitalization6.61M4.55M145%
EBITDA-7.87M-12.02M66%
Gain YTD-97.888-91.736107%
P/E Ratio0.01N/A-
Revenue00-
Total Cash4.75MN/A-
Total Debt131K1.63M8%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRINLSP
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISSC8.150.65
+8.67%
Innovative Solutions and Support
ARCC21.380.25
+1.18%
Ares Capital Corp
NPK93.450.70
+0.75%
National Presto Industries
CENTA33.82-0.38
-1.11%
Central Garden & Pet Company
ALZN1.11-0.14
-11.20%
Alzamend Neuro Inc.

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-3.90%
IDYA - GRI
54%
Loosely correlated
+3.31%
NLSP - GRI
38%
Loosely correlated
-18.07%
GOVX - GRI
37%
Loosely correlated
-1.29%
INAB - GRI
36%
Loosely correlated
+3.49%
SNSE - GRI
34%
Loosely correlated
+4.63%
More

NLSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NLSP has been loosely correlated with GRI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NLSP jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NLSP
1D Price
Change %
NLSP100%
-18.07%
GRI - NLSP
38%
Loosely correlated
-3.90%
GOVX - NLSP
30%
Poorly correlated
-1.29%
LOGC - NLSP
25%
Poorly correlated
+1.51%
MBIO - NLSP
25%
Poorly correlated
+1.64%
RLYB - NLSP
22%
Poorly correlated
-2.68%
More